Europe Is Emerging as the Next Growth Engine for Nicotine Pouches

GINN Statement | 30 July 2026 The latest half-year results from several of the world’s largest tobacco and nicotine companies reinforce a significant shift in the global nicotine market: growth in smoke-free products is increasingly extending beyond traditional Nordic markets, with Europe emerging as a major centre of demand, investment and innovation. Philip Morris International…

GINN Submission on Estonia’s Public Consultation on Proposed Amendments to the Tobacco Act and State Fees Act

Public Consultation Submission Submitted by: Global Institute for Novel Nicotine (GINN) Date: 28 July 2026 Contact: info@ginn.global Introduction The Global Institute for Novel Nicotine (GINN) welcomes the opportunity to provide comments on Estonia’s public consultation regarding the proposed amendments to the Tobacco Act and the State Fees Act. GINN is an independent international organisation dedicated…

Bangladesh’s Draft Nicotine Pouch Standard Signals a New Direction for Regulation

Why Product Standards May Matter More Than Product Bans As governments around the world consider how best to regulate emerging nicotine products, policy discussions often become polarized between those advocating prohibition and those supporting market access. Bangladesh’s latest initiative suggests there may be another path. The Bangladesh Standards and Testing Institution (BSTI) has released a…

Poland’s Nicotine Pouch Restrictions Highlight the Cost of Fragmented EU Regulation

Europe Needs a More Consistent Approach to Smoke-Free Nicotine Products Poland’s latest proposed tobacco legislation has placed nicotine pouches at the centre of a wider European regulatory debate. According to recent Polish government reporting, the proposed measures would ban disposable vaping products, tighten controls on nicotine pouches, restrict pouch flavours to tobacco only, and potentially…

Managing Risk, Not Ignoring It

What Oral Health Evidence Means for Nicotine Pouch Regulation As nicotine pouches become more widely available in global markets, questions about their long-term health effects continue to shape regulatory discussions. Among the most frequently debated issues is oral health. Reports of gum irritation, white lesions, gingival recession, and other local effects have prompted concerns from…

Australia’s Nicotine Pouch Ban Raises a Bigger Question About Harm Reduction

Australia has long been recognised as a global leader in tobacco control. It pioneered plain packaging, high tobacco taxes, advertising restrictions and comprehensive smoking reduction strategies, yet questions remain about how effective some of these measures have been in delivering the outcomes promised. Its latest reforms, however, mark a significant turning point in nicotine policy.…

Beyond Tobacco: Why Risk Should Guide Nicotine Regulation

For decades, tobacco control policies have been built around a straightforward premise: products containing tobacco should be regulated as tobacco products. This approach made sense when cigarettes, cigars, and smokeless tobacco dominated the market. Today, however, the nicotine landscape has changed significantly. A growing range of smoke-free products, including nicotine pouches, electronic cigarettes, heated tobacco…

Beyond Legislation: The Next Challenge for the UK’s Tobacco and Vapes Act

The United Kingdom’s Tobacco and Vapes Act marks one of the most significant tobacco control reforms in a generation. By introducing a “smoke-free generation” policy and strengthening the regulation of tobacco and vaping products, the legislation establishes an ambitious framework for reducing smoking prevalence and protecting future generations. But passing legislation is only the beginning.…

Real-World Evidence: The Missing Piece in Nicotine Policy

For decades, nicotine regulation has been built upon laboratory science, toxicological assessments, and clinical research. These forms of evidence remain indispensable for understanding product chemistry, biological mechanisms, and potential health effects. Yet as smoke-free nicotine products continue to evolve, regulators are increasingly recognising that scientific evidence alone does not always explain how products perform in…